Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Jackisch, Christian; Fasching, Peter A.; Grischke, Eva-Maria et al.
Median progression free survival (PFS) for patients treated with everolimus (EVE) plus exemestane (EXE) for HR plus mBC in routine clinical practice: Results of the 3rd interim analysis of the non-interventional trial BRAWO.JOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017
Makris, G. M.; Makrysopoulou, A.; Battista, M. J. et al.
Metastatic ovarian cancer and gastrointestinal stromal tumor on the grounds of neurofibromatosis. A case report and review of the literatureEUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. Bd. 38. H. 5. 2017 S. 790-792
Bayani, Jane; Yao, Cindy Q.; Quintayo, Mary Anne et al.
Molecular stratification of early breast cancer identifies drug targets to drive stratified medicineNPJ BREAST CANCER. Bd. 3. 2017
Schmidt, M
Multigentests zur Risikoabschätzung beim frühen MammakarzinomDer Gynäkologe. Bd. 50. 2017 S. 509-515
Schmidt, Marcus; Fehm, Tanja; Liedtke, Cornelia et al.
News from ASCO 2017BREAST CARE. Bd. 12. H. 4. 2017 S. 266-268
Makris, G. M.; Chrelias, C.; Papanota, A. et al.
Ovarian tumors: Should the cervix be examined first?EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. Bd. 38. H. 3. 2017 S. 462-464
Finn, Richard S.; Crown, John; Lang, Istvan et al.
Overall survival results from the randomized phase II study of palbociclib (P) in combination with letrozole (L) vs letrozole alone for frontline treatment of ER+/HER2-advanced breast cancer (PALOMA-1; TRIO-18).JOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017
Ishibashi, Kei; Haber, Tobias; Breuksch, Ines et al.
Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockadeONCOTARGET. Bd. 8. H. 33. 2017 S. 55230-55245
Kreipe, H; Schmidt, M
Pathologie, Prognose und PrädiktionColloquium Senologie 2017/2018. München: Agileum Verlagsgesellschaft mbH 2017
Dinkic, C.; Eichbaum, M.; Schmidt, M. et al.
Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant,recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trialGYNECOLOGIC ONCOLOGY. Bd. 146. H. 2. 2017 S. 279-284